Position Paper Medicines Shortages

29 September 2017

Policy

Position paper Reading list Report Address medicine shortages in Europe

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

2017 Market Review – Biosimilar Medicines Markets – Policy Overview

12 September 2017

Report

Biosimilars — Can the dream of affordable cancer care come true?

8 September 2017

External Resource

A Clinician´s Guide to Biosimilars in Oncology: Understanding the Science of Extrapolation and Interchangeability

8 September 2017

External Resource

Value Added Medicines: Time to Adjust the HTA Decision Frameworks

5 September 2017

Report

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Letter from European and UK Life Sciences Organizations Underlining the Importance of Securing Ongoing Cooperation Between the UK and EU on Medicines

13 July 2017

Policy

Position Paper External Reference Pricing for Generic and Biosimilar Medicines

1 July 2017

Policy

The Benefits of Biosimilar Medicines

20 June 2017

Infographic